Karwaciak, I.; Sałkowska, A.; Karaś, K.; Dastych, J.; Ratajewski, M.
Targeting SIRT2 Sensitizes Melanoma Cells to Cisplatin via an EGFR-Dependent Mechanism. Int. J. Mol. Sci. 2021, 22, 5034.
https://doi.org/10.3390/ijms22095034
AMA Style
Karwaciak I, Sałkowska A, Karaś K, Dastych J, Ratajewski M.
Targeting SIRT2 Sensitizes Melanoma Cells to Cisplatin via an EGFR-Dependent Mechanism. International Journal of Molecular Sciences. 2021; 22(9):5034.
https://doi.org/10.3390/ijms22095034
Chicago/Turabian Style
Karwaciak, Iwona, Anna Sałkowska, Kaja Karaś, Jarosław Dastych, and Marcin Ratajewski.
2021. "Targeting SIRT2 Sensitizes Melanoma Cells to Cisplatin via an EGFR-Dependent Mechanism" International Journal of Molecular Sciences 22, no. 9: 5034.
https://doi.org/10.3390/ijms22095034
APA Style
Karwaciak, I., Sałkowska, A., Karaś, K., Dastych, J., & Ratajewski, M.
(2021). Targeting SIRT2 Sensitizes Melanoma Cells to Cisplatin via an EGFR-Dependent Mechanism. International Journal of Molecular Sciences, 22(9), 5034.
https://doi.org/10.3390/ijms22095034